Overview

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of ropinirole XR in the treatment of adults with Restless Legs Syndrome (RLS).
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole